| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael Feld | EVP CRO Pres. Life Sciences | 2026-01-26 | 75 | $202.73 | $15.20kSell |
| Michael David Garrison | EVP Pres Med.EssntlBioPharm | 2026-01-15 | 1,010 | $206.54 | $208.61kSell |
| Michael David Garrison | EVP Pres Med.EssntlBioPharm | 2026-01-15 | 3,054 | $167.91 | $512.80kBuy |
| Michael David Garrison | EVP Pres Med.EssntlBioPharm | 2026-01-15 | 2,454 | $209.00 | $512.89kSell |
| Michael David Garrison | EVP Pres Med.EssntlBioPharm | 2026-01-15 | 600 | $209.00 | $125.40kSell |
| Michael Feld | EVP CRO Pres. Life Sciences | 2025-12-26 | 74 | $196.08 | $14.51kSell |
| Michael David Garrison | EVP Pres Med.EssntlBioPharm | 2025-12-17 | 629 | $196.03 | $123.30kSell |
| Michael Feld | EVP CRO Pres. Life Sciences | 2025-12-01 | 75 | $193.36 | $14.50kSell |
| Bertram L. Scott | Director | 2025-11-07 | 217 | $176.58 | $38.32kSell |
| Michael Feld | EVP President Life Sciences | 2025-10-27 | 57 | $186.01 | $10.60kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 11.37% | 32,455,790 | $6.55B | Institution |
| Blackrock Inc | 9.72% | 27,752,308 | $5.60B | Institution |
| T Rowe Price Investment Management Inc | 5.69% | 16,232,632 | $3.28B | Institution |
| State Street Corp | 4.86% | 13,872,395 | $2.80B | Institution |
| First Eagle Investment Management LLC | 3.50% | 9,994,408 | $2.02B | Institution |
| Massachusetts Financial Services Co | 3.21% | 9,150,584 | $1.85B | Institution |
| Geode Capital Management LLC | 2.39% | 6,831,477 | $1.38B | Institution |
| Franklin Resources Inc | 2.36% | 6,737,604 | $1.36B | Institution |
| Jpmorgan Chase Co | 1.85% | 5,287,783 | $1.07B | Institution |
| Wellington Management Group LLP | 1.83% | 5,232,086 | $1.06B | Institution |